More people worldwide are becoming diabetics than any other serious affliction, by far. I see BMY getting back in it at some point, now loaded with cash.
Sparrow, sad to say, you're an obvious mental lightweight, not dissimilar to such "luminaries" as speddydick (otherwise known as premature-ejac), diximan #$%$ central) and others whose efforts have not left enough of an impression to remember their handles. Good luck in an unwittingly and continuous effort to provide props for the richest .00001 percent.
From what I've read, if you not tender your shares, you would have "appraisal rights" provided enough people -- at least 50 percent of shareholders -- agree to tender their shares. Those rights would mean that some Delaware court would decide what value your shares have and Salix would have to pay it. It is said that the value could be lower, about the same or higher.
If a majority don't decide to tender their shares, no merger can take place. Of course Salix has the right to extend the signup period (twice) to make sure enough sign up. I plan to tender my shares -- you at least save brokerage fees, although there likely will be a processing charge -- in the interest of timeliness. It likely would take a pregnant period to determine appraisal value, and even then you moth not make anything extra.
Received a notice from Charles Schwab today that Salix is asking shareholders to declare by Dec. 27 whether they are willing to surrender their shares for $32 a share. From what I could gather with limited further information, there appears to be no real downside to rejecting the offer. I'm sure more will come out on this soon.
You missed the most recent divvy. It's being paid next Tuesday to holders from last month.
Just a comment: one longtime friend who's had actually jaw-dropping investing success with an Illinois-based financial advisor said the individual told him, after he recently purchased another 2,000 shares for him, that EXC could well be bumping $40 by the spring. Said the rise will be mainly tied to increased natural gas prices.
After hearing of his so many successes, I plunked down the green for a little over 1,000 shares about three months ago. I liked to have the substantial dividend. But so far, It's one of his few picks that is in the red. That's one reason I'm particularly hopeful that the upside will come.
Let me break this down as simply as I can. I've been burned several times on reverse splits, so I speak from experience. I know quite well that you basically have the same amount of money after a reverse split, but the overriding point is you don't have nearly as many shares. Let's say APPA does a 1-100 reverse at .47 cents and I have 10,000 shares. Suddenly I have 100 shares selling for $47 a share. I have the same money, but not nearly the same appreciation potential because I'm left with 100 lousy shares.That's my point and MY ONLY POINT. Over the years, it's been driven home to me that if you like a company, accumulate enough shares that you can make some real money if you're right.
For instance, I've been following SNTS for a long time, eventually rounding up 4,000 shares at an average cost of below $5. It had reached $23 and change when it received a $32 buyout offer. So that has been a nice hit. It's still sobering to realize that another person accumulated 155,000 shares and thousands more in options. Now that's a formula for changing your life in a positive way -- have a ton of shares and be right.
You say a reverse split may not affect share value. I think you are the one who hasn't thought it through. In practical terms, if my holdings are reduced from 10,000 shares to say in an extreme case, 100, I'm out of luck no matter how much the stock appreciates from there. The point: you can't make money with 100 shares. But with 10,000, every penny it appreciates is worth $100.
Meanwhile the Pentagon has $8.5 TRILLION in expenditures that it can't explain. Here's an understatement: you guys have selective vision on what you want to be "outraged" about. Not a peek about this new report.
If you had exposure to a better education, you might have some clue when to use "affect" and when to use "effect."
Never said anything about finding more informed people on any message board. And certainly not from an individual with apparent clown tendencies such as yourself. All I said, after hearing of repeated notable stock successes from a friend who has big money with a certain financial advisor, is that the advisor is still high on HLF, that he believes it has legs into the $90s.
For some reason that sent you into some incoherent rant. By the way, too small a sample size to draw any conclusions, but HLF was up $3 today.
You don"t make a heckuva lot of sense by just shrugging off what anybody/everybody has to say. Some people are far more savvy than others, or at least better informed. If you doubt that, I have some underwater land I'd like to interest you in.
You don't know me, but I don't play these games. i realize the curse of the Internet is that anyone can make any assertion he/she wants without providing the first shred of evidence of the voracity. If I had a horse in this race, I'd be more inclined to just spit out the name of the entity putting its clients' money into HLF. But, as I said, I generally don't pursue companies that rise to HLF's price range. The best I can offer is this: this entity has a Morningstar 4-star rating, so perhaps you can find which ones in that rating group are big on HLF. If you think you have an answer, I will confirm or do a thumbs down.
Aside: I've been somewhat baffled that HLF has gone from $37 to its present range. My friend thought about selling, but was told there's more to come.
For what it's worth, and it's a gambling's edge stock, a noted financial advisor tells an affluent friend of mine that Herbalife has another big run left, approaching $90. Too rich for my blood, as they say, but this is legit info.
Speedy acknowledges sending a "somewhat" racial message. I say he's just recertified his membership in the Klan.
Saw one analyst characterized the deal as favoring SNTS, because of two drugs going off patent in '16. But this kind of legal pressure on Salix might well produce something positive for remaining shareholders. Still, not sure what would make these legal beagles happy. Doubt we'll see $40, but perhaps $35.
At last count, I have 11. And I'm guessing there will be another straggler or two before it's over. In my limited frame of reference, this has translated into an increased buyout price. But it has taken time, months and months.
Should have added: Seeking Alpha is not exactly the most reputable outlet to deliver such news. If they didn't get it right, they will apologize while a number of investors will have already run for the door. Just the same, at this moment, it appears at least concening.
BDSI's reply will be telltale. the complaintant is an international company that you have to believe would have better things to do than file a frivolous lawsuit. But here's hoping that BDSi will have a meaningful response to ease shareholder concerns.